Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus

The Journal of Clinical Endocrinology and Metabolism
E T ShapiroK S Polonsky

Abstract

Eleven patients with noninsulin-dependent diabetes mellitus were studied before and after 6-10 weeks of glyburide therapy. Patients were studied during a 24-h period on a mixed diet comprising 30 Cal/kg divided into three meals. The following day a hyperglycemic clamp study was performed, with glucose levels clamped at 300 mg/dL (16.7 mmol/L) for a 3-h period. Insulin secretion rates were calculated by deconvolution of peripheral C-peptide concentrations using individual C-peptide clearance kinetics derived after bolus injection of biosynthetic human C-peptide. After 6-10 weeks on glyburide, the identical studies were repeated. In response to glyburide, the fasting plasma glucose level decreased from 12.3 +/- 1.2 to 6.8 +/- 0.9 mmol/L. Although the mean glucose over the 24 h of the meal study decreased from 12.7 +/- 1.4 to 10.8 +/- 1.2 mmol/L, postprandial hyperglycemia persisted on therapy, and after breakfast, glucose levels exceeded 10 mmol/L and did not return to fasting levels for the remainder of the day. Fasting serum insulin, plasma C-peptide, and the insulin secretion rate were not different before (152 +/- 48 pmol/L, 0.82 +/- 0.16 pmol/mL, and 196 +/- 34 pmol/min, respectively) and after (186 +/- 28 pmol/L, 0.91 +/- 0...Continue Reading

Citations

Jul 1, 1992·Diabetes/metabolism Reviews·W Creutzfeldt, M Nauck
Jun 4, 1999·European Journal of Pharmacology·N FurukawaK Wakitani
Dec 1, 2001·Endocrinology and Metabolism Clinics of North America·H E Lebovitz
Jun 5, 2003·Clinics in Podiatric Medicine and Surgery·Robert SkullyKevin W Lutz
Sep 3, 1992·The New England Journal of Medicine·S DinneenR Rizza
Aug 1, 1992·Diabetic Medicine : a Journal of the British Diabetic Association·H J GjessingO Pedersen
Jun 27, 2002·Clinical Pharmacokinetics·Vibeke Hatorp
Dec 7, 2016·International Journal of Experimental Pathology·Shadae R FosterLowell L Dilworth
Jan 5, 2000·Hospital Practice·G P SamrajL Kuritzky
Apr 14, 2016·American Journal of Physiology. Endocrinology and Metabolism·Sudha S ShankarDavid E Kelley
Nov 17, 2006·The Journal of Biological Chemistry·Jean ButeauDomenico Accili
Apr 22, 2006·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Matthew C Riddle
Aug 20, 1990·The American Journal of Medicine·N M O'MearaK S Polonsky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.